Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Assets (2016 - 2025)

Akebia Therapeutics (AKBA) has disclosed Return on Assets for 8 consecutive years, with 0.32% as the latest value for Q4 2024.

  • On a quarterly basis, Return on Assets fell 11.0% to 0.32% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.32%, a 11.0% decrease, with the full-year FY2024 number at 0.3%, down 13.0% from a year prior.
  • Return on Assets was 0.32% for Q4 2024 at Akebia Therapeutics, down from 0.18% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.18% in Q1 2024 to a low of 0.62% in Q1 2021.
  • A 5-year average of 0.39% and a median of 0.36% in 2020 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -28bps in 2021, then surged 34bps in 2023.
  • Akebia Therapeutics' Return on Assets stood at 0.58% in 2020, then rose by 14bps to 0.5% in 2021, then skyrocketed by 52bps to 0.24% in 2022, then increased by 10bps to 0.22% in 2023, then plummeted by -49bps to 0.32% in 2024.
  • Per Business Quant, the three most recent readings for AKBA's Return on Assets are 0.32% (Q4 2024), 0.18% (Q1 2024), and 0.22% (Q4 2023).